Inhalon Biopharma Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
2ndary - Private
- Investors
-
17
Inhalon Biopharma General Information
Description
Developer of an inhaled immunotherapy designed to treat a variety of acute respiratory infections. The company's platform seeks to harness the power of biologics designed for mucosal applications in treating and preventing respiratory infections, enabling doctors to trace the pathogens in mucus secretions for treating diseases of the respiratory tract.
Contact Information
Website
www.inhalon.comCorporate Office
- 5151 McCrimmon Parkway
- Suite 220
- Morrisville, NC 27560
- United States
Corporate Office
- 5151 McCrimmon Parkway
- Suite 220
- Morrisville, NC 27560
- United States
Inhalon Biopharma Timeline
Inhalon Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 9. Later Stage VC (Series A) | 01-Dec-2023 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 01-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 7. Grant | 01-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 12-Jul-2022 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 01-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Debt - General | 01-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 16-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 26-May-2021 | $7M | Completed | Pre-Clinical Trials | ||
| 1. Grant | $4M | Completed | Pre-Clinical Trials |
Inhalon Biopharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Inhalon Biopharma Patents
Inhalon Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023275534-A1 | Compositions and methods for inhalable therapeutics | Pending | 23-May-2022 | ||
| EP-4529467-A2 | Compositions and methods for inhalable therapeutics | Pending | 23-May-2022 | ||
| EP-4529467-A4 | Compositions and methods for inhalable therapeutics | Pending | 23-May-2022 | ||
| WO-2023230486-A2 | Compositions and methods for inhalable therapeutics | Inactive | 23-May-2022 | ||
| WO-2023230486-A3 | Compositions and methods for inhalable therapeutics | Inactive | 23-May-2022 | C07K16/104 |
Inhalon Biopharma Signals
Inhalon Biopharma Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambrian Growth Partners | Growth/Expansion | Minority | ||
| K2X | Venture Capital | Minority | ||
| Rivermount VC Fund | Venture Capital | Minority | ||
| SCP Ventures | Venture Capital | Minority | ||
| Ulmus Investment | Venture Capital | Minority |
Inhalon Biopharma FAQs
-
When was Inhalon Biopharma founded?
Inhalon Biopharma was founded in 2018.
-
Where is Inhalon Biopharma headquartered?
Inhalon Biopharma is headquartered in Morrisville, NC.
-
What is the size of Inhalon Biopharma?
Inhalon Biopharma has 9 total employees.
-
What industry is Inhalon Biopharma in?
Inhalon Biopharma’s primary industry is Drug Discovery.
-
Is Inhalon Biopharma a private or public company?
Inhalon Biopharma is a Private company.
-
What is Inhalon Biopharma’s current revenue?
The current revenue for Inhalon Biopharma is .
-
How much funding has Inhalon Biopharma raised over time?
Inhalon Biopharma has raised $11.1M.
-
Who are Inhalon Biopharma’s investors?
Cambrian Growth Partners, K2X, Rivermount VC Fund, SCP Ventures, and Ulmus Investment are 5 of 17 investors who have invested in Inhalon Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process